108139
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
氧化锌纳米颗粒通过抑制 NF-κB 和 JAK1-STAT1/STAT3 通路以及降低活性氧水平来减轻脂多糖诱导的 RAW264.7 巨噬细胞炎症反应
Authors Tang H , Zhang L, Deng C, Li Y, Ren G, Sun Z, Chang L, Xu M, Xiao D, Zhang H
Received 16 April 2025
Accepted for publication 26 September 2025
Published 9 October 2025 Volume 2025:18 Pages 14075—14096
DOI https://doi.org/10.2147/JIR.S534720
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Ning Quan
Hui Tang,1,2 Li Zhang,1,2 Chengchen Deng,2,3 Yuechuan Li,2,3 Guiying Ren,2,4 Ziru Sun,2,4 Lebing Chang,2,4 Meihong Xu,2,4 Duanqiang Xiao,2,4 Haijun Zhang1,2
1Department of Interventional and Vascular Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, 200072, People’s Republic of China; 2National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Dezhou, Shandong, 251100, People’s Republic of China; 3Key Laboratory for Biorheological Science and Technology of Ministry of Education, National Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing, 400044, People’s Republic of China; 4School of Materials Science and Engineering, Shandong University of Technology, Zibo, Shandong, 255000, People’s Republic of China
Correspondence: Haijun Zhang, Department of Interventional and Vascular Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, No. 301, Middle Yanchang Road, Shanghai, 200072, People’s Republic of China, Email zhanghaijun@tongji.edu.cn
Background: Macrophage-mediated inflammatory signaling drives pathological inflammation in diverse diseases. Zinc oxide nanoparticles (ZnO NPs) exhibit recognized anti-inflammatory activity, but their precise molecular mechanisms remain unclear. This study investigates the modulatory effects of ZnO NPs on Lipopolysaccharide (LPS)-induced inflammatory and underlying pathways in RAW264.7 macrophages.
Methods: Scanning electron microscopy (SEM) was used to analyze the primary particle sizes of ZnO NPs. Their cytotoxicity on RAW264.7 cells was assessed using the CCK-8 assay. Cells were pretreated with ZnO NPs (0, 0.5, 1, 2, 5 μg/mL) for 1 h, then stimulated with LPS (1 μg/mL) for 24 h. Pro-inflammatory factors (TNF-α, IL-1β, IL-6, iNOS, and COX-2), as well as the anti-inflammatory factor Arg-1, were detected using qRT-PCR, ELISA, or Western blot. RNA-sequencing identified differentially expressed genes (DEGs). Nitric oxide (NO) production, Reactive Oxygen Species (ROS).
Results: ZnO NPs reduced LPS-induced production of NO and pro-inflammatory factors but increased Arg-1 expression. RNA-sequencing identified 2638 DEGs (1822 upregulated, 816 downregulated) between LPS and LPS+ZnO NPs groups. Mechanistically, ZnO NPs exerted anti-inflammatory effects through: (1) blocking NF-κB activation by inhibiting IκB-α degradation and p65 nuclear translocation; (2) suppressing JAK1-mediated STAT1/3 activation and nuclear translocation. They also reduced LPS-induced ROS.
Conclusion: ZnO NPs mitigate LPS-triggered inflammation by targeting NF-κB and JAK1-STAT1/3 pathways, and reducing ROS. These findings provide novel mechanistic insights into the anti-inflammatory effects of ZnO NPs, highlighting their therapeutic potential in macrophage-associated inflammatory disorders.
Keywords: macrophages, ZnO NPs, inflammatory cytokine, NF-κB signaling pathway, JAK-STAT signaling pathway, ROS
1Department of Interventional and Vascular Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, 200072, People’s Republic of China; 2National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Dezhou, Shandong, 251100, People’s Republic of China; 3Key Laboratory for Biorheological Science and Technology of Ministry of Education, National Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing, 400044, People’s Republic of China; 4School of Materials Science and Engineering, Shandong University of Technology, Zibo, Shandong, 255000, People’s Republic of China
Correspondence: Haijun Zhang, Department of Interventional and Vascular Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, No. 301, Middle Yanchang Road, Shanghai, 200072, People’s Republic of China, Email zhanghaijun@tongji.edu.cn
Background: Macrophage-mediated inflammatory signaling drives pathological inflammation in diverse diseases. Zinc oxide nanoparticles (ZnO NPs) exhibit recognized anti-inflammatory activity, but their precise molecular mechanisms remain unclear. This study investigates the modulatory effects of ZnO NPs on Lipopolysaccharide (LPS)-induced inflammatory and underlying pathways in RAW264.7 macrophages.
Methods: Scanning electron microscopy (SEM) was used to analyze the primary particle sizes of ZnO NPs. Their cytotoxicity on RAW264.7 cells was assessed using the CCK-8 assay. Cells were pretreated with ZnO NPs (0, 0.5, 1, 2, 5 μg/mL) for 1 h, then stimulated with LPS (1 μg/mL) for 24 h. Pro-inflammatory factors (TNF-α, IL-1β, IL-6, iNOS, and COX-2), as well as the anti-inflammatory factor Arg-1, were detected using qRT-PCR, ELISA, or Western blot. RNA-sequencing identified differentially expressed genes (DEGs). Nitric oxide (NO) production, Reactive Oxygen Species (ROS).
Results: ZnO NPs reduced LPS-induced production of NO and pro-inflammatory factors but increased Arg-1 expression. RNA-sequencing identified 2638 DEGs (1822 upregulated, 816 downregulated) between LPS and LPS+ZnO NPs groups. Mechanistically, ZnO NPs exerted anti-inflammatory effects through: (1) blocking NF-κB activation by inhibiting IκB-α degradation and p65 nuclear translocation; (2) suppressing JAK1-mediated STAT1/3 activation and nuclear translocation. They also reduced LPS-induced ROS.
Conclusion: ZnO NPs mitigate LPS-triggered inflammation by targeting NF-κB and JAK1-STAT1/3 pathways, and reducing ROS. These findings provide novel mechanistic insights into the anti-inflammatory effects of ZnO NPs, highlighting their therapeutic potential in macrophage-associated inflammatory disorders.
Keywords: macrophages, ZnO NPs, inflammatory cytokine, NF-κB signaling pathway, JAK-STAT signaling pathway, ROS